Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells - sprookjes - yvandenbroek - TriplyDB

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

http://www.wikidata.org/entity/Q28359571

about

Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.Applications of magnetic resonance spectroscopy in radiotherapy treatment planning.(1)H NMR studies distinguish the water soluble metabolomic profiles of untransformed and RAS-transformed cells Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.Choline metabolism in malignant transformation.Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors Metabolic reprogramming in mutant IDH1 glioma cells.Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups.Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Choline metabolism in cancer: implications for diagnosis and therapy.Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancer Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.MR evaluation of response to targeted treatment in cancer cells.Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.Molecular imaging of tumor metabolism and apoptosis.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer.

P2860

Q28477468-1EF13A91-FEC8-448E-ABE1-931960E6F3F5 Q28486529-610674E1-BC64-4239-9313-53FEB24C4B5A Q30744878-43B21A12-40F3-4630-A98A-1DBE2CB00370 Q30808489-34EFC954-4F4D-48BB-93E9-0370DCF0F428 Q31061313-4B885488-392A-408F-85DF-105A0B4D5812 Q31109746-60748F6F-4E39-492E-A19E-863EB62EC518 Q33844954-CBC1F5B7-5676-479D-A231-EB44FF16C9A1 Q33959529-ABD63607-263F-4036-AD1C-FF0AE32DD959 Q34140986-A7D78B93-6873-4DDF-8DB7-3A1A8D1F3E4F Q35060329-153663A3-B1E8-40A5-B548-BB2B1DDAE8C8 Q35112040-612E9DC0-4AD4-4A99-A48A-DC9E85CF2D64 Q35374872-A8EE6708-D0C6-45D2-83E5-9507BB97DCAD Q35566048-204D909B-22BA-4A01-A1E1-7F427D8C6277 Q36287393-EECE01A8-5E9B-422B-9DAF-829A69C07C03 Q36488080-208B71FB-E51A-4735-832E-9B02DC9D4F0A Q36630017-022B1F44-D048-45B0-A1B5-655E13B63740 Q36670926-84AE7C6D-A94E-4121-AED2-890A4F7164FF Q37260499-32AB4817-2815-464F-BA15-1558E1765DBC Q37359297-BC7C75BB-544F-49D4-9119-3EAAE56D98F9 Q37374479-49BCD7F0-0932-4611-8778-9004DF890CC8 Q37559012-5177F301-C5AC-4EBB-A2DA-3A9C05CB7D54 Q37576912-0320C77F-5566-4B36-A30F-69020867F7A9 Q37638188-A2CBF09E-FE5B-4E3A-BAD2-D2689605D345 Q37725471-7430E9E6-F71B-4538-AB6D-2B97D70F1417 Q37851076-9018CF46-8CFA-4E79-AC6E-6BDC83090C13 Q37871191-05E9F256-7729-4E3C-B3DC-FDCA9B11760B Q37876191-B491AC3D-20D0-4F08-8BD4-D19A8C8E8793 Q37906482-668E8779-4220-43BD-8DF9-C3A99A29DD20 Q39007170-697123BD-4087-429F-A8EF-8257DBF05C64 Q39761744-FE78C22C-2D1D-40B3-9579-50791A693638 Q39795389-2C24B330-0787-4556-BDCE-A4D0E9A414A0 Q41939336-265AB37F-FCED-480E-AC21-FE0893595B83 Q44161878-6BF2B4B0-8486-4264-AECB-7351CAE9B635 Q49887915-71EB9658-6A80-497F-AE95-4841BA543B2E

P2860

Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

http://www.wikidata.org/entity/Q28359571

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

name

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@ast

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@en

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@nl

type

label

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@ast

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@en

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@nl

prefLabel

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@ast

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@en

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@nl

P1433

Q28359571-46429F40-2DDB-4413-84FF-59F140FDCDF8

P1476

Q28359571-6D3895E9-70FE-46F2-A77C-7A17727B79BC

P2093

Q28359571-0F801DB3-D23F-4D96-B57E-ED47F3FE1803

Q28359571-DC967579-9DC6-4E30-8589-D0D3A62A13A1

Q28359571-E949AEBF-C37E-46C3-9370-8FC3147F7650

Q28359571-F8C8AE77-3E89-4580-B538-6078E97B8FE4

P2860

Q28359571-0C04C40B-FD67-44E2-88E7-FFA5C7DC3058

Q28359571-0C04FE5D-6C13-43C6-AADC-960EE94D5E15

Q28359571-1C94B87E-95BE-4B19-B56D-69B3F5293751

Q28359571-3A662199-0EBF-47F0-B971-68B5420DD31B

Q28359571-3FC43E62-749D-4C92-B9E8-8F047E12D899

Q28359571-4553D334-7540-4C96-9628-8C13C8C35B57

Q28359571-4C995B4D-E888-458F-A9C7-092E21E55121

Q28359571-5B6E81FF-1FC5-47BE-ADC6-58C55ABAD9B1

Q28359571-6305DCF9-8E62-4F3D-B6E6-8DA98432A1F1

Q28359571-7847984B-6A09-405D-998F-D0876A9A901E

P2888

Q28359571-610919FB-2B6F-4391-A9A3-8BD3D3AD2FE3

P304

Q28359571-890AA04A-9E96-45DC-8759-4317ED8F07B5

P31

Q28359571-E182B62A-F86F-4668-84A9-6F1A59875D0D

P3181

Q28359571-AD3C0F54-4F95-4D4F-8253-742B3104CB87

P356

Q28359571-E641587E-CA41-4F84-A554-92FBE83BF8C7

P407

Q28359571-596CCA1A-C27C-420F-9989-E3917FFB6EA5

P433

Q28359571-7AE86572-2B61-4ABA-9F5E-3DFD5D870EBD

P478

Q28359571-CB6D4FC4-0D15-498D-9645-729646A63886

P577

Q28359571-D9B4FF62-8705-4266-9961-2E32498452B4

P5875

Q28359571-D87E317B-A96D-47B3-B30C-604AB04EAA24

P6179

Q28359571-9EC03B8E-A205-49C2-9F5C-7742094932A2

P698

Q28359571-76D8FF8A-2C59-41E4-ADCE-9AD829077521

P932

Q28359571-F100807F-04A7-4A12-B2F0-819F9EE510A7

P3181

P356

P1433

British Journal of Cancer

P1476

Magnetic resonance detects cha ...... nd inhibition in NIH 3T3 cells

@en

P2093

L E Jackson

http://www.w3.org/2001/XMLSchema#string

M Beloueche

http://www.w3.org/2001/XMLSchema#string

M O Leach

http://www.w3.org/2001/XMLSchema#string

S M Ronen

http://www.w3.org/2001/XMLSchema#string

P2860

cPLA2 is phosphorylated and activated by MAP kinase

Studies of human tumors by MRS: a review.

Tumour phospholipid metabolism.

The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate

Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.

Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis

Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy.

Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.

Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.

Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

P2888

P304

691-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

988836

http://www.w3.org/2001/XMLSchema#string

P356

10.1054/BJOC.2000.1663

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12095300

http://www.w3.org/2001/XMLSchema#string

P6179

1008241862

http://www.w3.org/2001/XMLSchema#string

P698

11237392

http://www.w3.org/2001/XMLSchema#string

P932

2363797

http://www.w3.org/2001/XMLSchema#string